Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Faxon

Showing results (91-100 of 176) with videos related to

Pageof 18
Sort By:
Heart (British Cardiac Society)|February 14, 2018
Cochrane corner: complete versus culprit-only revascularisation in ST segment elevation myocardial infarction with multivessel diseaseClaudio A Bravo, Sameer A Hirji, Deepak L Bhatt, et al.
American Heart Journal|February 15, 2011
Temporal changes in the outcomes of patients with diabetes mellitus undergoing percutaneous coronary intervention in the National Heart, Lung, and Blood Institute dynamic registryElizabeth M Holper, J Dawn Abbott, Suresh Mulukutla, et al.
Circulation|December 21, 2006
Nonfinancial incentives for quality: a policy statement from the American Heart AssociationVincent Bufalino, Eric D Peterson, Harlan M Krumholz, et al.
Heart (British Cardiac Society)|July 26, 2015
Outcomes with prolonged clopidogrel therapy after coronary stenting in patients with chronic kidney diseaseOmar K Siddiqi, Kyle J Smoot, Alyssa B Dufour, et al.
Circulation|March 30, 2006
Recommendation to develop strategies to increase the number of ST-segment-elevation myocardial infarction patients with timely access to primary percutaneous coronary interventionAlice K Jacobs, Elliott M Antman, Gray Ellrodt, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 19, 2016
Long-term outcomes in patients with acute coronary syndromes related to prolonging dual antiplatelet therapy more than 12 months after coronary stentingNeil J Wimmer, Alyssa B Dufour, Kelly Cho, et al.
The American Journal of Cardiology|January 25, 2011
Risk of death and myocardial infarction in patients with peripheral arterial disease undergoing percutaneous coronary intervention (from the National Heart, Lung and Blood Institute Dynamic Registry)Shailja V Parikh, Shoaib Saya, Punag Divanji, et al.
Journal of the American College of Cardiology|October 14, 2008
2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic SurgeonsRobert O Bonow, Blase A Carabello, Kanu Chatterjee, et al.
Nature Reviews. Cardiology|February 19, 2026
Invasive and medical management approaches to non-acute myocardial ischaemic syndromesNicholas Chiu, Deepak L Bhatt, Raffaele De Caterina, et al.
Journal of the American College of Cardiology|December 5, 2016
Cangrelor Use Since FDA Approval: A Single-Center, Real-World Experience at a Tertiary Care HospitalMuthiah Vaduganathan, Arman Qamar, Abhayjit Singh, et al.
Pageof 18

Showing results (91-100 of 176) with videos related to

Sort By:
Pageof 18
Heart (British Cardiac Society)|February 14, 2018
Cochrane corner: complete versus culprit-only revascularisation in ST segment elevation myocardial infarction with multivessel diseaseClaudio A Bravo, Sameer A Hirji, Deepak L Bhatt, et al.
American Heart Journal|February 15, 2011
Temporal changes in the outcomes of patients with diabetes mellitus undergoing percutaneous coronary intervention in the National Heart, Lung, and Blood Institute dynamic registryElizabeth M Holper, J Dawn Abbott, Suresh Mulukutla, et al.
Circulation|December 21, 2006
Nonfinancial incentives for quality: a policy statement from the American Heart AssociationVincent Bufalino, Eric D Peterson, Harlan M Krumholz, et al.
Heart (British Cardiac Society)|July 26, 2015
Outcomes with prolonged clopidogrel therapy after coronary stenting in patients with chronic kidney diseaseOmar K Siddiqi, Kyle J Smoot, Alyssa B Dufour, et al.
Circulation|March 30, 2006
Recommendation to develop strategies to increase the number of ST-segment-elevation myocardial infarction patients with timely access to primary percutaneous coronary interventionAlice K Jacobs, Elliott M Antman, Gray Ellrodt, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 19, 2016
Long-term outcomes in patients with acute coronary syndromes related to prolonging dual antiplatelet therapy more than 12 months after coronary stentingNeil J Wimmer, Alyssa B Dufour, Kelly Cho, et al.
The American Journal of Cardiology|January 25, 2011
Risk of death and myocardial infarction in patients with peripheral arterial disease undergoing percutaneous coronary intervention (from the National Heart, Lung and Blood Institute Dynamic Registry)Shailja V Parikh, Shoaib Saya, Punag Divanji, et al.
Journal of the American College of Cardiology|October 14, 2008
2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic SurgeonsRobert O Bonow, Blase A Carabello, Kanu Chatterjee, et al.
Nature Reviews. Cardiology|February 19, 2026
Invasive and medical management approaches to non-acute myocardial ischaemic syndromesNicholas Chiu, Deepak L Bhatt, Raffaele De Caterina, et al.
Journal of the American College of Cardiology|December 5, 2016
Cangrelor Use Since FDA Approval: A Single-Center, Real-World Experience at a Tertiary Care HospitalMuthiah Vaduganathan, Arman Qamar, Abhayjit Singh, et al.
Pageof 18